ZBD | $40,000,000 | (Jan 23, 2026)
Halcyon Futures | $4,200,000 | (Jan 23, 2026)
Asymmetric Security | $4,200,000 | (Jan 23, 2026) Certified by Founder
Lodge
Synthetic Design Lab
start up
United States
- San Francisco Bay Area
- 24/04/2025
- Unknown
- $20,000,000
A next-generation ADC company developing a novel SYNTHBODY therapeutic platform against a range of cancer types
- Industry Biotechnology Research
- Website https://www.syntheticdesignlab.com/
- LinkedIn https://www.linkedin.com/company/synthetic-design-lab-inc/
Related People
Daniel Chen, M.D. Ph.D.Founder
United States -
Burlingame, California
Author of The Cancer-Immunity Cycle (Immunity 2013) and the Cancer-Immune Set Point (Nature 2017) with Ira Mellman.
A pioneer in the field of Cancer Immunotherapy, emergence of PD-L1/PD-1 inhibitors and next generation therapies. Focused on the future of medicine and what's possible at the intersection between engineering, science and medicine.
Experienced drug developer (from pre-clinical through Phase I-IV), entrepreneur, executive- strong communicator and strategic leader with expertise in Oncology, Immunology, Large Molecule Engineering, Virology, Filings, Biomarkers and Building/Leading Organizations.
Cubby | $63,000,000 | (Jan 23, 2026)
Cambio | $18,000,000 | (Jan 23, 2026)
Yuki | $6,000,000 | (Jan 23, 2026)
Artie Technologies | $12,000,000 | (Jan 23, 2026)
One to One Health | $12,000,000 | (Jan 22, 2026)
AnswersNow | $40,000,000 | (Jan 22, 2026)
Claim Health | $4,400,000 | (Jan 22, 2026)
Nasdaq Private Market | $37,600,000 | (Jan 22, 2026)
PraxisPro | $6,000,000 | (Jan 22, 2026)